Kadant Inc. (KAI) Market Cap & Valuation Ratios
Kadant Inc. (KAI) has a market cap of $3.1B, a trailing P/E of 28.2 and a price-to-sales ratio of 2.7, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-07-04 · read by EquiReason
KAIKadant Inc.Follow KAI — free
—
Price chart with a free account
- Market cap
- 3.1B
- P/E TTM
- 28.2
- Dividend yield
- 0.5%
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
Peers
specialty industrial machinery · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| KAI | 3.1 | 28.2 | 3.0 | 15.1 | 5.2% | +13% | 15% | 10% |
| FELE | 4.3 | 28.3 | 2.0 | 13.0 | 5.0% | +7% | 13% | 14% |
| XE | 4.3 | — | — | — | — | — | -202% | — |
| MIR | 3.7 | 148.1 | 4.4 | 21.8 | 3.6% | +16% | 5% | 2% |
| MWA | 3.5 | 15.7 | 2.3 | 10.2 | 5.2% | +6% | 19% | 22% |
| CXT | 3.3 | 23.6 | 2.5 | 11.9 | 6.8% | +17% | 14% | 9% |
| SXI | 2.9 | — | 3.6 | 14.0 | 2.2% | +13% | 22% | 14% |
| SMR | 2.3 | — | 116.0 | — | — | -81% | — | -87% |
| HLIO | 2.2 | 30.9 | 2.7 | 16.2 | 4.8% | +14% | 10% | 6% |
| CHRN | 2.2 | — | 22.3 | 313.8 | 1.1% | -15% | -56% | -37% |
| HSAI | 2.1 | — | — | — | — | +46% | 6% | 2% |
| Median of these 10 | 28.3 | 3.2 | 14.0 | 4.8% | +13% | 10% | 6% |
P/E 28.2 vs. a peer median of 28.3; EV/Sales 3.0 vs. 3.2. KAI's own P/E sits at the 39th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesXE and SXI and SMR and CHRN and HSAI have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Kadant Inc. — questions
- What is Kadant Inc.'s market cap?
- $3.1B.
- What is Kadant Inc.'s P/E ratio?
- 28.2 on trailing twelve-month earnings to 2026-07-04.
- What is Kadant Inc.'s price-to-sales ratio?
- 2.7.
Every figure on this page comes from Kadant Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.